Lineage Cell Therapeutics
LCTX
#8763
Rank
A$0.34 B
Marketcap
A$1.37
Share price
-4.01%
Change (1 day)
-49.62%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2026 (TTM): -A$39.39 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are A$13.08 Million. In 2025 the company made an earning of -A$31.27 Million a decrease over its 2024 earnings that were of -A$30.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$39.39 Million25.98%
2025 -A$31.27 Million1.4%
2024 -A$30.83 Million-13.16%
2023 -A$35.51 Million9.83%
2022 -A$32.33 Million-54.24%
2021 -A$70.64 Million86.07%
2020 -A$37.97 Million-31.97%
2019 -A$55.81 Million-5.42%
2018 -A$59 Million1.1%
2017 -A$58.36 Million-31.06%
2016 -A$84.65 Million-10.38%
2015 -A$94.46 Million29.69%
2014 -A$72.84 Million31.68%
2013 -A$55.32 Million
2011 -A$26.85 Million89.78%
2010 -A$14.15 Million206.06%
2009 -A$4.63 Million-0.58%
2008 -A$4.65 Million164.89%
2007 -A$1.76 Million-30.22%
2006 -A$2.52 Million
2002 -A$2.93 Million-41.04%
2001 -A$4.96 Million-32.04%
2000 -A$7.29 Million-11.85%
1999 -A$8.27 Million
1997 -A$5.32 Million12.12%
1996 -A$4.74 Million106.25%
1995 -A$2.3 Million-11.11%
1994 -A$2.59 Million50%
1993 -A$1.73 Million20%
1992 -A$1.44 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.23 Billion 481.52%๐Ÿ‡บ๐Ÿ‡ธ USA